Centre for Amyloidosis and Acute Phase Proteins
- Division of Medicine
- Centre Homepage
- News
- Staff List
- Research Groups
- National Amyloidosis Centre
- Amyloidosis Research Fund
- Key Publications
- Patents
- Awards
- Links
- Contact Us
National Amyloidosis Centre
Clinical Staff
| Head/Clinical Director | Professor Philip Hawkins | +44 (0)20 7433 2815/2816 |
|
Emeritus Professor/Consultant |
Professor Sir Mark Pepys |
+44 (0)20 7433 2801 |
| Senior Lecturers/Consultants | Dr Julian Gillmore | +44 (0)20 7433 2726 |
|
|
Dr Helen Lachmann | +44 (0)20 7433 2804 |
|
|
Dr Ashutosh Wechalekar | +44 (0)20 7433 2758 |
|
|
Dr Carol Whelan | +44 (0)20 7433 2875 |
|
Clinical Fellows |
Dr Marianna Fontana |
+44 (0)20 7433 2823 |
| Dr Shameem Mahmood |
+44 (0)20 7433 2770 |
|
|
Dr Ketna Patel |
+44 (0)20 7433 2823 |
|
|
Dr Sajitha Sachchithanantham |
+44 (0)20 7433 2763 |
|
|
Dr Rabya Sayed |
+44 (0)20 7433 2823 |
|
| Clinical Research Nurses |
Thirusha Lane (Lead) |
+44 (0)20 7433 2759 |
|
Darren Foard |
+44 (0)20 7433 2814 |
|
|
Lisa Rannigan |
+44 (0)20 7433 2732 |
|
|
Rene Williams |
+44 (0)20 7433 2797 |
|
|
Clinic Coordinator |
Eleanor Pyart |
+44 (0)20 7433 2738 |
|
Clinic Nurses |
Alica Bangova |
+44 (0)20 7433 2799 |
|
Annie Hughes |
+44 (0)20 7433 2730 |
|
|
Appointments & Office Administrator |
Ramon Lamarca |
+44 (0)20 7433 2813 |
|
Academic PA to Consultants |
+44 (0)20 7433 2816 |
|
|
Unit Secretaries |
+44 (0)20 7433 2798/2811/2816 |
|
|
Transport & Accommodation |
+44 (0)20 7433 2812 |
|
|
General Enquiries |
+44 (0)20 7433 2725 |
|
|
Fax |
+44 (0)20 7433 2817 |
The NHS National Amyloidosis Centre is the only centre in the UK specialising in amyloidosis and is part of University College London Centre for Amyloidosis and Acute Phase Proteins, one of the world’s leading centres for amyloid research. The Centre has “state of the art” clinical and research facilities, and a team of highly qualified clinical, research and support staff.
We pioneered scintigraphic imaging (scanning) of amyloid as a quantitative diagnostic procedure and provide a comprehensive clinical service for patients with all types of acquired and hereditary systemic amyloidosis. The NHS National Amyloidosis Centre is commissioned by the NHS National Specialised Commissioning team and funded by the Department of Health to provide a diagnostic and management advice service for the UK’s national caseload of patients with amyloidosis and related disorders. We have evaluated over 5000 patients. The clinical service includes:
- Detailed clinical assessment.
- Diagnosis, quantification and monitoring of amyloidosis with whole body SAP scintigraphy.
- Review of diagnostic biopsies and specialised immunohistochemistry to determine amyloid type.
- Characterisation and exclusion of hereditary amyloidosis by DNA testing; genetic counselling.
- Additional imaging studies when appropriate, which may include DPD scanning and cardiac MRI scanning.
- Recommendations for treatment and monitoring response.
- Measurement and monitoring of specialised biochemical (blood) tests for serum free light chains and serum amyloid A protein.
- 3‑12 monthly follow‑up to assess response and further treatment requirements. Sometimes follow‑up assessment can be performed by telephone if patients live far away.
- Providing information and support to amyloidosis patients, their families and health providers.
- Systematic evaluation of existing and new treatments.
- Diagnosis, monitoring and treatment of inherited fever syndromes.
